Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MediCabilis for Long COVID
NCT04997395Phase 2Completed
- Sponsor
- Bod Science Limited
- Start
- Apr 2022
- Primary completion
- Jan 2023
- Modality
- Plant-derived medicinal product
- Countries
- 1
01
Overview
A Phase 2 trial of cannabis sativa in post-COVID-19 condition (PCC), sponsored by Bod Science Limited. Started Apr 2022; status: completed.
02
Drugs
cannabis sativa
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT04997395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04997395.